Real-world comparative safety and effectiveness of rivaroxaban versus warfarin in patients with non-valvular atrial fibrillation: a prospective cohort study.
- DOI
- 10.1080/03007995.2026.2706317
- Published
- 2026 Jun
- Container
- Current medical research and opinion
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/03007995.2026.2706317,
title = {Real-world comparative safety and effectiveness of rivaroxaban versus warfarin in patients with non-valvular atrial fibrillation: a prospective cohort study.},
author = {Alsubaie N and Ali Shah Z and Ilyas M and Alrossies AS and Binsaleh AY and Muzammil Shah S},
year = {2026},
journal = {Current medical research and opinion},
doi = {10.1080/03007995.2026.2706317},
url = {https://doi.org/10.1080/03007995.2026.2706317}
}RIS
TY - JOUR TI - Real-world comparative safety and effectiveness of rivaroxaban versus warfarin in patients with non-valvular atrial fibrillation: a prospective cohort study. AU - Alsubaie N AU - Ali Shah Z AU - Ilyas M AU - Alrossies AS AU - Binsaleh AY AU - Muzammil Shah S PY - 2026 JO - Current medical research and opinion DO - 10.1080/03007995.2026.2706317 UR - https://doi.org/10.1080/03007995.2026.2706317 ER -
APA
N, A., Z, A. S., M, I., AS, A., AY, B., & S, M. S. (2026). Real-world comparative safety and effectiveness of rivaroxaban versus warfarin in patients with non-valvular atrial fibrillation: a prospective cohort study.. Current medical research and opinion. https://doi.org/10.1080/03007995.2026.2706317
Source records
- pubmed · retrieved 2026-09-27T10:50:57.407Z